세계의 모르핀 시장 규모, 점유율, 성장 분석 : 형태별, 유통 채널별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Morphine Market Size, Share, Growth Analysis, By Form (Oral Tablets, Injection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드:1630743
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 01월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
모르핀 세계 시장 규모는 2023년 300억 3,000만 달러로 평가되었습니다. 또한 2024년 323억 4,000만 달러에서 2032년 585억 5,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 7.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
제약 산업의 주요 부문인 세계 모르핀 시장은 특히 고령화로 인한 만성통증 증가로 강력한 진통제에 대한 수요가 증가함에 따라 효과적인 통증 관리 솔루션을 제공하는 데 주력하고 있습니다. 모르핀은 암이나 수술 후 회복과 같은 질병으로 인한 극심한 통증을 완화하는 역할을 하기 때문에 병원이나 완화의료센터와 같은 의료 시설에서 여전히 중요한 역할을 하고 있습니다. 그러나 이 시장에는 남용과 중독 위험과 같은 문제가 있어 의료 서비스 제공업체가 신중하게 관리해야 합니다. 이러한 장애물에도 불구하고, 기술 발전, 혁신적인 약물 처방, 완화 치료의 성장은 시장 확대의 큰 기회를 부각시키고, 궁극적으로 통증이 심한 환자의 삶의 질을 향상시키는 데 기여할 것입니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구
모르핀 시장 규모 : 형태별 & CAGR(2025-2032년)
시장 개요
경구 정제
주사
캡슐
기타
모르핀 시장 규모 : 유통 채널별 & CAGR(2025-2032년)
시장 개요
병원 약국
소매 약국
온라인 약국
기타
모르핀 시장 규모 : 용도별 & CAGR(2025-2032년)
시장 개요
통증 관리
설사 억제제
감기 및 기침약
기타
모르핀 시장 규모 : 최종사용자별 & CAGR(2025-2032년)
시장 개요
병원 및 클리닉
외래수술센터(ASC)
기타
모르핀 시장 규모 : 지역별 & CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년대비 비교(2022-2024)
주요 기업 개요
Pfizer Inc.(USA)
Teva Pharmaceutical Industries Ltd.(Israel)
Hikma Pharmaceuticals PLC(UK)
Mallinckrodt Pharmaceuticals(Ireland)
Boehringer Ingelheim GmbH(Germany)
Gerot Lannach(Austria)
Dongbei Pharmaceutical Group Co.(China)
Taiji Group Southwest Pharmaceutical Co.(China)
Sun Pharmaceutical Industries Ltd.(India)
Sanofi S.A.(France)
Johnson & Johnson(USA)
Novartis International AG(Switzerland)
GlaxoSmithKline plc(UK)
AstraZeneca plc(UK)
Eli Lilly and Company(USA)
Bayer AG(Germany)
Roche Holding AG(Switzerland)
Merck & Co., Inc.(USA)
결론과 추천 사항
LSH
영문 목차
영문목차
Global Morphine Market size was valued at USD 30.03 billion in 2023 and is poised to grow from USD 32.34 billion in 2024 to USD 58.55 billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).
The global morphine market, a key segment of the pharmaceutical industry, is focused on providing effective pain management solutions stemming from rising demands for potent analgesics amid increasing chronic pain conditions, particularly within the aging demographic. As morphine serves to alleviate severe pain associated with ailments like cancer and postoperative recovery, its presence in medical facilities, including hospitals and palliative care centers, remains critical. However, the market grapples with challenges such as potential abuse and addiction risk, necessitating careful management by healthcare providers. Despite these hurdles, advancements in technology, innovative drug formulations, and the growth of palliative care highlight significant opportunities for market expansion, ultimately contributing to improved quality of life for patients experiencing intense pain.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Morphine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Morphine Market Segmental Analysis
Global Morphine Market is segmented by Form, Distribution Channel, Application, End User and region. Based on Form, the market is segmented into Oral Tablets, Injection, Capsule and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on Application, the market is segmented into Pain Management, Diarrhea Suppressant, Cold & Cough Suppressant and Others. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Morphine Market
The global morphine market is significantly influenced by the rising prevalence of chronic pain disorders. An increasing number of individuals suffering from conditions such as cancer, musculoskeletal issues, and neuropathic pain is a key market driver. According to the World Health Organization's projections from 2022, the incidence of cancer cases is expected to rise by almost 50% over the next twenty years. This surge in chronic pain cases has escalated the demand for effective analgesics, particularly morphine, thereby contributing to the overall growth of the morphine market as healthcare providers seek to offer adequate pain management solutions.
Restraints in the Global Morphine Market
The global morphine market encounters significant restraints primarily due to a stringent regulatory environment that governs opioid medications. To combat the growing epidemic of opioid misuse, addiction, and overdose, governments and healthcare authorities have implemented rigorous regulations, including restrictions on prescriptions, monitoring programs, and stringent guidelines for safe usage. While these measures aim to curtail the opioid crisis, they inadvertently pose considerable challenges for manufacturers and healthcare providers, hindering compliance and limiting access to morphine for patients who genuinely require it for medical treatment. Consequently, the balance between ensuring safety and maintaining necessary availability remains a pressing issue within the sector.
Market Trends of the Global Morphine Market
The Global Morphine market is experiencing a significant trend towards personalized pain management, with a growing emphasis on individualized treatment strategies that consider patient-specific characteristics, genetics, and unique pain profiles. This paradigm shift is fueled by advances in pharmacogenomics, which enable healthcare providers to optimize opioid therapy by identifying patients at higher risk for adverse responses. Research, including a pivotal 2022 study in the Journal of Pain and Symptom Management, highlights the potential of tailored approaches to enhance therapeutic outcomes for patients requiring morphine. As the focus on precision medicine intensifies, the demand for morphine is likely to rise, particularly among targeted patient demographics.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Global Morphine Market Size by Form & CAGR (2025-2032)
Market Overview
Oral Tablets
Injection
Capsule
Others
Global Morphine Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Morphine Market Size by Application & CAGR (2025-2032)
Market Overview
Pain Management
Diarrhea Suppressant
Cold & Cough Suppressant
Others
Global Morphine Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals & Clinics
Ambulatory Surgical Centers
Others
Global Morphine Market Size & CAGR (2025-2032)
North America (Form, Distribution Channel, Application, End User)
US
Canada
Europe (Form, Distribution Channel, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Form, Distribution Channel, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Form, Distribution Channel, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Form, Distribution Channel, Application, End User)
